Aran Frank Labrijn PhD

Dr. Aran F. Labrijn has been working in the field of recombinant antibodies for more than 20 years. He holds a PhD in molecular immunology from the University of Amsterdam (2004). In 2002, he joined Genmab where he is currently a principal scientist in the department of antibody research and technology with a focus on understanding antibody biology and Fc-engineering. These studies have led to the development of therapeutic antibody formats, including Genmabs bispecific antibody technology platform.